About Cytena
Cytena is a Healthcare company based in Freiburg Im Breisgau (Germany) founded in 2014, and was acquired by CELLINK in August 2019. Single cells are isolated using the cy-Clone device technology. Cytena has raised $4.59 million across 2 funding rounds from investors including CELLINK and High-Tech Gründerfonds. Its website cytena.com draws about 21 thousand monthly visits. Cytena offers products and services including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is CYTENA GmbH.
Company details
Founded in 2014, Cytena operates in the biotechnology sector focused on cell analysis tools. The cy-Clone device is utilized for separating individual cells, supporting biological drug development and genetic studies in cancer and stem cell research. An automated imaging system is integrated to encapsulate cells within droplets, enabling delivery to diverse substrates for further applications.
Products & Services of Cytena
Cytena offers a comprehensive portfolio of products and services, including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS.
Optimizes monoclonality proof and cell tracking in research.
Enables rapid dispensing of fluorescent cells for assays.
Facilitates powerful dispensing of unlabeled cells in workflows.
Automates washing and dispensing for reproducible lab processes.
Apps and channels of Cytena
its YouTube channel CYTENA has 152 subscribers and 30 videos.
Videos from Cytena
The most watched videos on Cytena's YouTube channel, CYTENA (152 subscribers). Click a video to play it here.
More on CYTENA.
Funding Insights of Cytena
Cytena has successfully raised a total of $4.59M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.39 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.59M
- Total Rounds 2
- Last Round Series A — $3.39M
- First Round $1.2M
(Apr 2015)
- Investors Count 1
All 2 funding rounds of Cytena with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Cytena
Cytena has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CELLINK and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
3D bioprinters and bioinks are developed for research applications. | 2016 | cellink.com | Boston, United States |
Investor details for Cytena
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cytena
6 people are tracked at Cytena (2 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Fernando Aprile García | Director Of Applications Global R&d | Leadership |
Jolanda Scheenhart | Head Of Sales Europe - Biopharma | Leadership |
Hesham Iftekhar Ahmad | Software Engineer | Team |
Justin Loo | Sales Team Lead Biosciences | Team |
Jochen Huck | Software Project Lead | Team |
Kushal Kumar Das | Sales Specialist Biopharma (central Europe) | Team |
Complete people profiles for Cytena
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cytena
4 dated milestones of Cytena across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Cytena is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Series A, of $3.4M.
- Exit Acquired by CELLINK.
Web traffic of Cytena
The website of Cytena (cytena.com) receives about 20.8K visits a month.
- Monthly visits20.8K
▼ 16.2% vs previous month
Websites whose visitors overlap most with Cytena. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| discover-echo.com | 100% | 28.3K | #1,115,289 | View details | |
| sptlabtech.com | 90% | 23.8K | #1,239,423 | View details | |
| ptglab.com | 85% | #137,673 | View details | ||
| bio-techne.com | 83% | 218.1K | #187,423 | View details | |
| moleculardevices.com | 80% | 131.7K | #329,224 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Cytena
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytena
Complete news archive for Cytena
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytena
Cytena was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Cytena is headquartered in Freiburg Im Breisgau, Germany. It is registered at Freiburg Im Breisgau, Baden-wurttemberg, Germany.
Cytena is a funded company, having raised a total of $4.59M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Apr 2015.
Founded in 2014, Cytena operates in the biotechnology sector focused on cell analysis tools. The cy-Clone device is utilized for separating individual cells, supporting biological drug development and genetic studies in cancer and stem cell research. An automated imaging system is integrated to encapsulate cells within droplets, enabling delivery to diverse substrates for further applications.
Cytena offers UP.SIGHTâ„¢ 2nd Gen, F.SIGHTâ„¢ 2.0, C.SIGHTâ„¢ 2.0, and C.WASHâ„¢ PLUS.
Cytena has 2 investors. Key investors include CELLINK, and High-Tech Gründerfonds.
Cytena operates through Cytena Gmbh.
Yes. Cytena was acquired by CELLINK in August 2019.

